After getting clobbered nearly 12% over the past few session after announcing a delay in top-line FLINT study results, Intercept ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE